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Background
HIV is associated with an increased risk of cardiovascular disease (CVD) and related clinical events. While traditional risk factors
play an important role in the pathology of cardiovascular disease, HIV infection and its sequelae of immune activation and
inflammation may have significant effects on the myocardium before becoming clinically evident. Cardiac MRI (CMR) can be
used to detect the pattern of these subclinical changes. This will lead to a better understanding of risk factors contributing to
cardiovascular disease prior to it becoming clinically significant in HIV-positive patients.
Methods
Prospective cohort study of 127 asymptomatic HIV-positive men on ART compared to 35 matched controls. Baseline
demographics, HIV parameters, 12-lead ECG, routine biochemistry, and traditional cardiovascular risk factors were recorded.
Images were acquired on a 3T Achieva Philips MRI scanner with 5 channel phase array cardiac coil and weight-based IV
gadolinium was given at 0.15 mmol/kg dose with post-contrast inversion recovery imaging after 10 minutes.
Results
6/127 (4.7%) of asymptomatic HIV-positive men had late gadolinium enhancement (LGE) on MRI verses 1/35 (2.9%) in the
control group. In 3/6 (50%) of cases this was in a classical infarction pattern with subendocardial involvement. 3/6 (50%) were
consistent with prior myocarditis. There was no significant difference in mean LVEF (66.93% vs 65.18%), LVMI (60.05g/m
2 vs
55.94g/m
2) or posterolateral wall thickness (8.28 mm and 8.16 mm) between cases and controls respectively. There was
significantly more diastolic dysfunction, E:A ratio B1, found in the HIV-positive group, 18% vs 7% of controls (p 0.037).
Framingham risk did not predict either of these outcomes.
Conclusions
There is an increased incidence of LGE detected on CMR in this asymptomatic HIV-positive cohort. Two distinct pathological
processes were identifed as causing these changes, myocardial infarction and myocarditis. These findings were independent of
traditional cardiac risk factors, duration of HIV infection and ART therapy. Sub clinical cardiac dysfunction may be underreported
in other cardiac evaluation studies. The true impact of other potential risk factors may also be underestimated, highlighting the
need for the development of more complex prediction models.
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